Global Pediatric Perfusion Market Forecast, Trend Analysis And Competition Tracking - Market Insights: 2015 – 2031

Global Pediatric Perfusion Market Introduction

The global pediatric perfusion market was valued at US$ XXXX million in 2020, and is projected to grow at a CAGR of X.X%.

Request Covid - 19 Impact

Pediatric perfusion is a procedure that is used to increase blood flow to the brain of a child suffering from a stroke or other condition that has decreased brain perfusion. The most common causes of cerebral circulatory insufficiency are birth asphyxia, intracranial hemorrhage, and arteriovenous malformations.

The American Academy of Pediatrics (AAP) defines pediatric perfusion as “the process by which oxygenated blood is delivered to the body’s organs, tissues, and cells.” Pediatric perfusion can be compromised by congenital heart defects or cardiac disease. The AAP recommends that pediatric perfusion be evaluated in every new-born with congenital heart disease, cyanotic congenital heart disease, or clinical suspicion of congestive heart failure.

The demands on the pediatric perfusionists are varied. Their responsibility is to manage diseases or conditions that disrupt oxygen flow to the body, such as a congenital heart defect or pulmonary embolism. In addition, pediatric cardiologists often rely on perfusionists to identify coronary blood flow deficiencies by measuring oxygen saturation in small vessels.

A major focus in the field of pediatric perfusion is the dissemination of knowledge on anatomical features, physiology, pharmacology, and clinical considerations related to key organs in children. Pediatric anatomic differences are also important when applying advanced imaging techniques. These differences need to be considered when developing protocols for clinical trials, which are often conducted in infants.

The goal of pediatric perfusion is to understand how blood flow affects the growth and development of the cardiovascular system. The heart is an organ that pumps oxygen-rich blood through cavities called arteries, which lead to organs and tissues throughout the body. Blood vessels called veins bring back blood to the heart. Circulatory diseases are conditions that affect how well this system works, such as congenital abnormalities, infections, toxins, cardiovascular disease, and illnesses affecting the lungs.

Pediatric perfusion is advantageous because it can detect both intracranial and extracranial vascular abnormalities. Pediatric perfusion is also advantageous because it has the ability to differentiate between different types of vascular obstructions. Pediatric perfusion is advantageous because it can be performed without contrast dye which may not always be necessary in children.

However, disadvantages of pediatric perfusion are broad. The pediatric body is different physiologically from an adult, which means that making sure the equipment is appropriately sized for the patient's size is crucial. Pediatric perfusion physicians also have to take into account other implications, such as cerebral blood flow, renal flow, body temperature control. Furthermore, the size of vascular accesses in children are smaller than adults and might not be able to handle fluid administration or return.

The global pediatric perfusion market is segregated into product types, end user, and regions. On the basis of product type, the global pediatric perfusion market is sub-segmented into pediatric cannulae, pediatric centrifugal blood pumps, pediatric arterial line filters, hemoconcentrators, HMS plus hemostasis management system, and pediatric oxygenation system. With respect to end user, the global pediatric perfusion market is distributed into hospitals, ambulatory surgical centers, clinics, and other end users. On the basis of region, the global pediatric perfusion market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Rising Prevalence Of Congenital Heart Disease

Increasing prevalence of congenital heart disease is expected to boost growth of pediatric perfusion. The market is seeing an increase in new cases of congenital heart disease due to the increased incidence of mothers over the age of 30. This increases the risk of having a baby with cardiac abnormalities, which will lead to increased demand for pediatric perfusion services.

Increasing awareness about the new treatment of various cardiac abnormalities

The advent of new techniques for the treatment of congenital and acquired cardiac abnormalities has ushered in a growing awareness about the efficacy of such treatment. Accompanied by increasing information emanating from clinical trials, these interventions have been shown to produce significantly improved outcome measures when compared to standard treatments.

Rising demand for minimally invasive effective technology

The growing demand for minimally invasive effective technology is augmenting growth of pediatric perfusion, which are techniques that are often used to assist children born with congenital heart defects. This means that the introduction of new technology into the medical field can be an important tool for hospitals to use in order to maintain a steady flow of patients. Children who have open-heart surgery are typically first treated with cardiopulmonary bypass, which filters blood outside of the body for oxygenation.

Increasing adoption of pediatric perfusion technology to treat congenital heart

The growing adoption of pediatric perfusion technology to treat congenital heart disease is based on the evidence that this procedure significantly increases the number of patients with uni-ventricular hearts that survive into adulthood. The use of this type of treatment to correct pulmonary valve stenosis, which is a condition in which the valve between the lower right chamber (the ventricle) and the pulmonary artery becomes narrowed to impede blood flow, has also been shown to increase long-term survival rates.

High cost coupled with pediatric cardiac heart surgeries which is unaffordable by low middle income countries

Pediatric cardiac heart surgeries are often very expensive and too costly for low-middle income countries. The high cost of these surgeries poses a problem for many families in the lower-income class as they cannot afford or seek out this type of surgery. Many low-middle income countries do not have the necessary funds to pay for these types of operations so it is seen as an unaffordable luxury.

COVID-19 Impact Analysis on Global Pediatric Perfusion Market

The healthcare industry has taken a lot of accountability for dealing with the COVID-19 patients. At the same time, it has reached obstacles similar to that experienced by other sectors. In these circumstances, the health sector has had to remain at the vanguard of advancements and find newer and more effective ways to treat patients. Historically, the demand for medical services due to changes in patient health and preferences has had notable upsurges.

North America is expected to dominate the global market

The global pediatric perfusion market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Markets in the North America are expected to account for the largest share owing to the new product launches by many key players, growing prevalence of heart disease in children, and growing demand for effective technologies used during heart surgeries.

Competitive Landscape

• MEDIVATORS Inc.

• LivaNova PLC

• Terumo Cardiovascular Systems Corporation.

• Medtronic

• BL Lifesciences

• Koninklijke Philips N.V.

• EUROSETS

• General Electric Company

• Terumo Medical Corporation

• Sorin Group

• Other Key Players

Report Scope

• Forecast Period: 2022-2031

• Actual Year: 2021

• Historical Data Available for: 2015-2020

Key Segments Covered

Global Pediatric Perfusion Market by Product Type

• Pediatric Cannulae

• Pediatric Centrifugal Blood Pumps

• Pediatric Arterial Line Filters

• Hemoconcentrators

• HMS Plus Hemostasis Management System

• Pediatric oxygenation System

Global Pediatric Perfusion Market by End User

• Hospitals

• Ambulatory Surgical Centers

• Clinics

• Other End Users